Atlas Trials

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma

Clinical trial NCT04787991 · COMPLETED

Trial details

NCT number
NCT04787991
Sponsor
Cancer Insight, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Pancreatic Adenocarcinoma
Start date
2021-08-09
Primary completion
2024-11-12
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.